Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit

Annals of Neurology

Volumn 42, Issue 4, 1997, Pages 595-603

  Galvin, James E ^a   Lee, Virginia M Y ^a   Baba, Minami ^b   Mann, David M A ^c   Dickson, Dennis W ^d   Yamaguchi, Hisako ^b   Schmidt, M Luise ^a   Iwatsubo, Takeshi ^b   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; NEUROFILAMENT PROTEIN; PROTEIN SUBUNIT;

ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; DEMENTIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CEREBRAL CORTEX; HUMANS; HYBRIDOMAS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MICROSCOPY, IMMUNOELECTRON; NEUROFILAMENT PROTEINS;

EID: 0030826626     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420410     Document Type: Article

References (63)

1. Lewy F. Zur pathologischen Anatomie der Paralysis agitans. Dtsch Z Nervenheilkd 1913;50:50-55
2. Gibb WRG, Poewe VVH. The centenary of Friederich H. Lewy. Neuropathol Appl Neurobiol 1986;12:217-221
3. Greenfield JG, Bosanquet FD. The brainstem lesions in parkinsonism. J Neurol Neurosurg Psychiatry 1953;16:213-226
4. Forno LS. Pathology of parkinsonism, a preliminary report of 24 cases. J Neurosurg 1966;24:266-271
5. Cronford ME, Chang L, Miller BL. The neuropathology of parkinsonism: an overview. Brain Cogn 1995;28:321-341
6. Galloway PG, Mulvihill P, Perry G. Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol 1992;140:809-822
7. Goldman JE, Yen SH, Chiu FC, Peress NS. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 1983;221:1082-1084
8. Hill WD, Lee VM-Y, Hurtig HI, et al. Epitopes located in spatially separate domains of each neurofilament subunit are present in the Lewy bodies of Parkinson's disease. J Comp Neurol 1991;109:150-160
9. Schmidt ML, Murray J, Lee VM-Y, et al. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 1991;139:53-65
10. Forno LS, Sternberger LA, Sternberger NH, et al. Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments. Neurosci Lett 1986;64:253-258
11. Mayer RJ, Lowe J, Lennox G, et al. Intermediate filament-ubiquitin diseases: implication for cell sanitization. Biochem Soc Symp 1989;55:193-201
12. Manetto V, Perry G, Tabaton M, et al. Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc Natl Acad Sci USA 1988;85:4501-4505
13. Lowe J, Blanchard A, Morrell K, et al. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 1988;155:9-15
14. Yamada T, McGeer PL, McGeer EG. Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins. Acta Neuropathol 1992;84:100-104
15. Papolla MZ, Adorn AC, Chou SM. Serum protein antigens with Lewy bodies of Parkinson's disease. Ann Neurol 1984;66:136 (Abstract)
16. Gai WP, Blumbergs PC, Blessing WW. Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease. Acta Neuropathol 1996;91:78-81
17. Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993;52:183-191
18. Samuel W, Galasko D, Masliah E, Hansen LA. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:44-52
19. Cummings JL. Lewy body diseases with dementia: pathophysiology and treatment. Brain Cogn 1995;28:266-280
20. Katzman R, Galasko D, Saitoh T, et al. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain Cogn 1995;28:259-265
21. Smith MC, Mallory M, Hansen LA, et al. Fragmentation of the neuronal cytoskeleton in the Lewy body variant of Alzheimer's disease. Neuroreport 1995;6:673-679
22. Kazee AM, Han LY. Cortical Lewy bodies in Alzheimer's disease. Arch Pathol Lab Med 1995;119:448-453
23. Hansen LA, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990;40:1-8
24. Hansen LA, Crain BJ. Making the diagnosis of mixed and non-Alzheimer's dementias. Arch Pathol Lab Med 1995;119:1023-1031
25. Olichney JM, Galasko D, Corey-Bloom J, Thal LJ. The spectrum of diseases with diffuse Lewy bodies. Adv Neurol 1995;65:159-170
26. Crystal HA, Dickson DW, Lizardi JE, et al. Antemortem diagnosis of diffuse Lewy body disease. Neurology 1990;40:1523-1528
27. Gibb WRG, Luthert PJ, Janota I, Lantos PL. Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 1989;52:185-192
28. Perry RH, Irving D, Blessed G, et al. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-139
29. Perry EK, McKeith I, Thompson P, et al. Topography, extent and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease and Alzheimer's disease. Ann NY Acad Sci 1991;640:197-202
30. Shibata N, Hirano A, Kobayashi M, et al. Cu/Zn superoxide dismutase-like immunoreactiviry in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett 1994;179:149-152
31. Schmidt ML, Carden MJ, Lee VM, Trojanowski JQ. Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. Lab Invest 1987;56:282-294
32. Mather K, Watts FZ, Carroll M, et al. Antibody to an abnormal protein in amyotrophic lateral sclerosis identifies Lewy body-like inclusions in ALS and Lewy bodies in Parkinson's disease. Neurosci Lett 1993;160:13-16
33. Lipkin LE. Cytoplasmic inclusions in ganglion cells associated with Parkinsonian states. Am J Pathol 1959;35:1117-1133
34. Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996;55:259-272
35. Schmidt ML, Lee VMY, Trojanowski JQ. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neuntes and neuropil threads. Lab Invest 1991;64:352-357
36. Bramblett GT, Goedert M, Jakes R, et al. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993;10:1089-1099
37. Iwatsubo T, Yamaguchi H, Fujimuro M, et al. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 1996;148:1517-1529
38. Perry G, Friedman R, Shaw G, Chau V. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer's disease brains. Proc Natl Acad Sci USA 1987;84:3033-3036
39. Lee VM-Y, Carden MJ, Schlaepfer WW, Trojanowski JQ. Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats. J Neurosci 1987;7:3474-3488
40. Hsu SM, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassays. Am J Clin Pathol 1981;75:734-738
41. Balin BJ, Lee VM. Individual neurofilament subunits reassembled in vitro exhibit unique biochemical, morphological and immunological properties. Brain Res 1991;556:198-208
42. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148
43. Jellinger K. New developments in the pathology of Parkinson's disease. In: Streifler MB, Korczyn AB, Melamed E, Youdin MBH, eds. Advances in neurology, Parkinson's disease: anatomy, pathology and therapy. New York: Raven Press, 1990, 53:1-16
44. Bethlem J, Jager W den H. The incidence and characteristics of Lewy bodies in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 1960;23:74-80
45. Masaki T, Ishiura S, Sugita H, Kwak S. Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy. J Neurol Sci 1994;122:127-134
46. Iwatsubo T, Nakano I, Fukunaga K, Miyamoto E. Ca2+/ calmodulin-dependent protein kinase II immunoreactivity in Lewy bodies. Acta Neuropathol 1991;82:159-163
47. Yamada T, McGeer PL, Baimbridge KG, McGeer EG. Relative sparing in Parkinson's disease of substantia nigra neurons containing calbindin-D 28K. Brain Res 1990;526:303-307
48. Arai H, Lee VMY, Hill WD, et al. Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease. Brain Res 1992;585:386-390
49. Hassler R. Zur pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387 (Abstract)
50. Klaue R. Parkinsonische Krankeit (Paralysis agitans) und postenzephlitischen Parkinsonismus. Arch Psychiatr Nervenkrankh 1940;11:251-321
51. Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmic inclusions (Lewy type) associated with progressive dementia and quadraparesis in flexion. J Neuropathol Exp Neurol 1961;20:237-244
52. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47:1113-1124
53. Hirsch E, Ruberg M, Portier MM, et al. Characterization of two antigens in parkinsonian Lewy bodies. Brain Res 1988;441:139-144
54. Pollanen MS, Bergeron C, Weyer L. Detergent-insoluble cortical Lewy body fibrils share epitopes with neurofilaments and τ. J Neurochem 1992;58:1953-1956
55. Pollanen MS, Bergeron C, Weyer L. Deposition of detergent-resistant neurofilaments into Lewy body fibrils. Brain Res 1993;603:121-124
56. Goldman JE, Yen SH. Cytoskeletal protein abnormalities in neurodegenerative diseases. Ann Neurol 1986;19:209-223
57. Wakabayashi K, Hansen LA, Masliah E. Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI 32. Acta Neuropathol 1995;89:404-408
58. Trojanowski JQ, Lee VMY. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias. Ann NY Acad Sci 1994;747:92-109
59. Cole JS, Messing A, Trojanowski JQ, Lee VMY. Modulation of axonal diameter and neurofilament by hypomyelinating Schwann cells in transgenic mice. J Neurosci 1994;14:6956-6966
60. Brion JP, Couck AM. Cortical and brainstem Lewy bodies are immunoreactive for cyclin dependent kinase 5. Am J Pathol 1995;147:1465-1476
61. Hill WD, Arai M, Cohen JA, Trojanowski JQ. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons. J Comp Neurol 1993;329:328-336
62. Bergeron C, Petrunka C, Weyer L, Pollanen MS. Altered neurofilament expression does not contribute to Lewy body formation. Am J Pathol 1996;148:267-272
63. Tu P-H, Robinson KA, de Snoo F, et al. Selective degeneration of Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice. J Neurosci 1997;17:1064-1074